Loading
CT
Cynapsus Therapeutics Inc. Stock: price and insider trades · Canada
Cynapsus Therapeutics Inc.: what insiders have been doing
Cynapsus Therapeutics Inc. has a thin disclosure history in our data (latest filing: 17 October 2016). New filings will appear here as soon as they are published. Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 17 October 2016
Declarations3 total
4,500 sharesCommon SharesTSXSEDI:2902987
620,325 shares@ CA$39.75100.0% of flowCommon SharesTSXSEDI:2888732
Common SharesTSXSEDI:2865399
3 of 3 declarations
About Cynapsus Therapeutics Inc.
Cynapsus Therapeutics Inc. is a biopharmaceutical company focused on developing treatments for neurological disorders. It is listed on the XTSE.
